Dual ProGlide versus ProGlide and FemoSeal for vascular access haemostasis after transcatheter aortic valve implantation.

MLA

Gmeiner, Jonas M. D., et al. “Dual ProGlide versus ProGlide and FemoSeal for Vascular Access Haemostasis after Transcatheter Aortic Valve Implantation.” EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, vol. 18, no. 10, Nov. 2022, pp. 812–19. EBSCOhost, https://doi.org/10.4244/EIJ-D-22-00311.

APA

Gmeiner, J. M. D., Linnemann, M., Steffen, J., Scherer, C., Orban, M., Theiss, H., Mehilli, J., Sadoni, S., Peterß, S., Joskowiak, D., Hagl, C., Tsilimparis, N., Curta, A., Maurus, S., Doldi, P. M., Löw, K., Haum, M., Roden, D., Hausleiter, J., … Braun, D. (2022). Dual ProGlide versus ProGlide and FemoSeal for vascular access haemostasis after transcatheter aortic valve implantation. EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 18(10), 812–819. https://doi.org/10.4244/EIJ-D-22-00311

Chicago

Gmeiner, Jonas M D, Marie Linnemann, Julius Steffen, Clemens Scherer, Martin Orban, Hans Theiss, Julinda Mehilli, et al. 2022. “Dual ProGlide versus ProGlide and FemoSeal for Vascular Access Haemostasis after Transcatheter Aortic Valve Implantation.” EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 18 (10): 812–19. doi:10.4244/EIJ-D-22-00311.